Author

T. M. Errington

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Bhargava· 1 shared A. Denis· 1 shared C. Gallagher· 1 shared C. Sutter· 1 shared E. Iorns· 1 shared J. Kerwin· 1 shared L. Yue· 1 shared N. Perfito· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhargava

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 30, 2021

Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

S. Pelech, C. Gallagher, C. Sutter…·T. M. Errington

This replication study confirms some findings of the original study on RAF inhibitors and their effects on MAPK pathway activation but reports discrepancies in key experiments.

DOI 10.1101/2021.11.30.470372

humanproteomics

𝕏 PostBluesky